Angion Biomedica Corp. (ANGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 2.2400 |
| Open | 2.3000 |
| Bid | 2.1500 x 900 |
| Ask | 2.5800 x 1100 |
| Day's range | 2.2000 - 2.3050 |
| 52-week range | 2.1500 - 26.3000 |
| Volume | |
| Avg. volume | 312,687 |
| Market cap | 67.702M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.0040 |
| Earnings date | 28 Mar 2022 - 01 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.00 |
- Simply Wall St.
Trade Alert: The President Of Angion Biomedica Corp. (NASDAQ:ANGN), Jay Venkatesan, Has Just Spent US$730k Buying 24% More Shares
Those following along with Angion Biomedica Corp. ( NASDAQ:ANGN ) will no doubt be intrigued by the recent purchase of...
- Zacks
Angion (ANGN) Kidney Drug Misses Third Study Goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fails to achieve the primary endpoint.
- Business Wire
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
ST. GALLEN, Switzerland & UNIONDALE, N.Y., December 10, 2021--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/
© 2022 Yahoo. All rights reserved.
